This Article Full Text Full Text (PDF) All Versions of this Article: 111/25/3429    most recent CIRCULATIONAHA.104.519652v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masuo, K. Articles by Tuck, M. L. Search for Related Content PubMed PubMed Citation Articles by Masuo, K. Articles by Tuck, M. L. Related Collections Obesity Clinical Studies

(Circulation. 2005;111:3429-3434.)
© 2005 American Heart Association, Inc.

Hypertension

ß₂- and ß₃-Adrenergic Receptor Polymorphisms Are Related to the Onset of Weight Gain and Blood Pressure Elevation Over 5 Years

Kazuko Masuo, MD, PhD; Tomohiro Katsuya, MD, PhD; Yuxiao Fu, MD; Hiromi Rakugi, MD, PhD; Toshio Ogihara, MD, PhD; Michael L. Tuck, MD

From the Human Neurotransmitter Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia (K.M.); Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan (K.M., T.K., Y.F., H.R., T.O.); and Metabolism and Endocrinology Division, Sepulveda VA Medical Center, and David Geffen UCLA School of Medicine, Los Angeles, Calif (M.L.T.).

Correspondence to Kazuko Masuo, MD, PhD, Baker Heart Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria 8008, Australia. E-mail kmasuo{at}baker.edu.au

Received November 5, 2004; revision received February 23, 2005; accepted March 4, 2005.

Background— The genes responsible for obesity are candidate genes for obesity-related diseases, such as hypertension. Functional polymorphisms in the ß₂- and ß₃-adrenergic receptors have been reported to be associated with hypertension and obesity.

Methods and Results— To longitudinally clarify the relevance to alterations in ß-adrenergic receptor polymorphisms related to weight gain, blood pressure (BP) elevation, and sympathetic nerve activity as measured by plasma norepinephrine level, we studied 160 young, nonobese, normotensive men. Changes in body weight, BP, plasma norepinephrine levels, and ß₂-adrenergic (Arg16Gly, Gln27Glu) and ß₃-adrenergic (Trp64Arg) receptor polymorphisms were measured periodically over a 5-year period. Weight gain and BP elevation were defined as 10% increases from entry levels over 5 years in body mass index or mean BP. The presence of the Gly16 allele of Arg16Gly was associated with a higher frequency of weight gain and BP elevation over the 5-year period. The subjects carrying the Glu27 allele of Gln27Glu and the Trp64 allele of Trp64Arg had a higher frequency of BP elevation. Significantly higher levels of plasma norepinephrine at entry and at year 5 were observed in the subjects with the Gly16 allele of Arg16Gly and the Glu27 allele of Gln27Glu compared with those without the Gly16 or the Glu27 alleles.

Conclusions— These results demonstrate that the Gly16 allele is related to greater weight gain and BP elevation. Additionally, Glu27 and Trp64 alleles are linked to BP elevation. The subjects carrying the ß₂-polymorphisms linked to weight gain and BP elevation also have higher plasma norepinephrine levels that are present at entry before weight gain and BP elevation. These findings suggest that ß₂-adrenergic receptor polymorphisms in association with a heightened sympathetic nerve activity could predict the future onset of obesity and hypertension, as shown in the 5-year longitudinal study.

Key Words: hypertension • norepinephrine • obesity

This article has been cited by other articles:

				M. Esler, N. Straznicky, N. Eikelis, K. Masuo, G. Lambert, and E. Lambert Mechanisms of Sympathetic Activation in Obesity-Related Hypertension Hypertension, November 1, 2006; 48(5): 787 - 796. [Full Text] [PDF]